Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome: genes and variants
Explore variant evidence for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome across 1 analyzed protein (MTOR). Linked ClinVar records include 13 pathogenic or likely pathogenic variants, 33 variants of uncertain significance and 20 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome
MTOR: Serine/threonine-protein kinase mTOR
It integrates nutrient, energy, oxygen, and growth-factor signals to control protein synthesis, autophagy, metabolism, and cell growth. Activating germline or mosaic variants can cause developmental brain overgrowth and epilepsy, while persistent pathway activation is common in cancer.
13 ClinVar pathogenic / likely pathogenic and 53 uncertain variants in MTOR have source records linked to Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MTOR F1888L | 1888 | FAT | Pathogenic / likely pathogenic (★★) |
| MTOR F1888C | 1888 | FAT | Pathogenic / likely pathogenic (★★) |
| MTOR E1799K | 1799 | FAT | Pathogenic / likely pathogenic (★★) |
| MTOR M2327I | 2327 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★) |
| MTOR V2406M | 2406 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★) |
| MTOR S2413I | 2413 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic (★★) |
| MTOR R1568G | 1568 | FAT | Pathogenic / likely pathogenic (★) |
| MTOR M1595I | 1595 | FAT | Pathogenic / likely pathogenic (★) |
| MTOR A1971V | 1971 | FAT | Pathogenic / likely pathogenic (★) |
| MTOR I2500M | 2500 | Pathogenic / likely pathogenic (★) | |
| MTOR D2512G | 2512 | Pathogenic / likely pathogenic (★) | |
| MTOR R2076Q | 2076 | Sufficient for interaction with the FKBP1A/rapam | Pathogenic / likely pathogenic |
| MTOR I2153V | 2153 | Pathogenic / likely pathogenic |
Which prediction tools work for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 90 out of 100
- PolyPhen-2: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 83 out of 100
Same protein, different disease
- Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes also has ClinVar records linked to MTOR variants; they fall mostly in different places as the Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome variants (12 pathogenic / likely pathogenic).
- Isolated focal cortical dysplasia also has ClinVar records linked to MTOR variants; they fall mostly in different places as the Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome variants (9 pathogenic / likely pathogenic).
- CEBALID syndrome also has ClinVar records linked to MTOR variants; they fall mostly in different places as the Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome variants (6 pathogenic / likely pathogenic).
Diseases related to Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome
- Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes, also linked to MTOR
- Isolated focal cortical dysplasia, also linked to MTOR
- CEBALID syndrome, also linked to MTOR
Frequently asked questions
Which genes have records linked to Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome?
This view contains 1 analyzed proteins: MTOR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 13 pathogenic or likely pathogenic variants, 33 variants of uncertain significance and 20 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 77 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center